BMPR1A-ENTPD1 Fusion FISH Probe
The BMPR1A-ENTPD1 Fusion FISH Probe is used to confirm a fusion of the BMPR1A and ENTPD1 genes. The fusion of the BMPR1A and ENTPD1 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| BMPR1A-ENTPD1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| BMPR1A-ENTPD1-20-AQAQ | 20 (40 μL) | 200 μL |
|
BMPR1A Gene Summary
The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. [provided by RefSeq, Jul 2008]
Gene Name: Bone Morphogenetic Protein Receptor Type 1A
Chromosome: CHR10: 88516395 -88684945
Locus: 10q23.2
ENTPD1 Gene Summary
The protein encoded by this gene is a plasma membrane protein that hydrolyzes extracellular ATP and ADP to AMP. Inhibition of this protein's activity may confer anticancer benefits. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2015]
Gene Name: Ectonucleoside Triphosphate Diphosphohydrolase 1
Chromosome: CHR10: 97471535 -97637023
Locus: 10q24.1
Gene Diseases
The BMPR1A ENTPD1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|